Ionis Pharmaceuticals (IONS) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 170.0 | 2.76 | 3.72 | 2.49 | 0.22 | 0.03 | |||
| Changes by years, y/y, % | +1 505% | -98% | +35% | -33% | -91% | -54.0% | |||
Ionis Pharmaceuticals. Debt/EBITDA
Ionis Pharmaceuticals. Debt/EBITDA, changes, %
Ionis Pharmaceuticals (IONS) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Debt/EBITDA | 0.53 | 5.19 | 4.89 | -0.01 | 0.03 | 0.03 | ||
| Changes by years, y/y, % | -42% | +100% | +17% | -101% | -95% | |||
| Changes by quarters, q/q, % | -79% | +888% | -6% | -100% | -294% | |||